NetraMark Holdings Inc. (TSX: AIAI)
AIAI trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for AIAI.TO, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | AIAI on the Toronto Stock Exchange |
| Yahoo symbol | AIAI.TO |
| Sector | Life Sciences |
| Headquarters | Ontario |
| Listed | 2026-02-18 |
| Listing type | Other |
| Shares outstanding | 92,648,699 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | 0.0% |
| 1 week | 0.0% |
| 1 month | -4.8% |
| 3 months | -9.1% |
| 6 months | -38.1% |
| Year to date | -45.5% |
| 1 year | -52.0% |
| From 52-week high | -50.4% |
| 52-week range | C$0.5000 to C$1.21 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
34 documents in 5 types. Each title links to the document at its source.
Annual financial statements (3)
| Document | Type | Filed |
|---|---|---|
| SEDAR Financial Statements Period Q4 2024 | Annual financial statements | 2024-09-30 |
| SEDAR Financial Statements Period Q4 2023 | Annual financial statements | 2023-09-30 |
| SEDAR Financial Statements | Annual financial statements | 2022-09-30 |
Interim financial statements (12)
| Document | Type | Filed |
|---|---|---|
| SEDAR Financial Statements Period Q3 2026 | Interim financial statements | 2026-06-30 |
| SEDAR Financial Statements Period Q2 2026 | Interim financial statements | 2026-03-31 |
| SEDAR Financial Statements Period Q1 2026 | Interim financial statements | 2025-12-31 |
| SEDAR Financial Statements Period Q3 2025 | Interim financial statements | 2025-06-30 |
MD&A (16)
| Document | Type | Filed |
|---|---|---|
| SEDAR MD&A Period Q4 2023 | MD&A (annual) | 2023-09-30 |
| SEDAR MD&A | MD&A (annual) | 2022-09-30 |
| SEDAR MD&A Period Q3 2024 | MD&A (interim) | 2024-06-30 |
| SEDAR MD&A Period Q2 2024 | MD&A (interim) | 2024-03-31 |
Annual information form (1)
| Document | Type | Filed |
|---|---|---|
| Annual Information Form Period FY2026 | Annual information form | 2026-01-15 |
Other (2)
| Document | Type | Filed |
|---|---|---|
| SEDAR Financial Statements Period FY2025 | Financial statements (period not stated) | 2026-05-21 |
| July 14, 2026 | NetraMark Holdings | Other | 2026-07-13 |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| OTC | Ocumetics Technology Corp. | TSXV | C$56.2M | -9.8% | -63.7% |
| ARCH | Arch Biopartners Inc. | TSXV | C$56.4M | +8.1% | -8.8% |
| WOLF | Grey Wolf Health Corp. | TSXV | C$57.2M | -5.2% | +24.1% |
| TELY | TelyRx Holdings Inc. | TSX | C$64.3M | -25.7% | Under a year of closes |
| TLT | Theralase Technologies Inc. | TSXV | C$46.3M | +5.6% | -5.0% |
The app has the price chart, every filing, private raises and the full peer set for AIAI.
Open in the app